Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial

<p><strong>BACKGROUND:</strong> Inhaled budesonide has shown efficacy for treating COVID-19 in the community but has not yet been tested in effectiveness trials.</p> <p><strong>METHODS:</strong> We performed a multicenter, open-label, multi-arm, adaptive pl...

Full description

Bibliographic Details
Main Authors: Yu, L-M, Ramakrishnan, S, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Hobbs, FDR, Butler, CC
Other Authors: PRINCIPLE Collaborative Group
Format: Journal article
Language:English
Published: Cold Spring Harbor Laboratory 2021

Similar Items